Neutra (NTRR) Stock Price, Quote, News & History

Neutra Corp (NTRR) Stock Price, Quote, News & History

NTRROTCID

Trade with Public

$0.00010

N/A

At close: Mar 27, 5:00 PM EST

$0.00020

0.0001100.00%

After Hours: Jul 11, 8:01 AM EST

Key Statistics

Open

$0.00

Volume / Avg.

108.51M / 2.70M

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.00

Market Cap

$304.29K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Neutra Corp News

Neutra To Acquire Private Clinical Research Site Management Organization

Neutra Corporation (OTCPK:NTRR) announced the execution of a binding letter of intent to acquire Mercury Clinical Research, a privately-owned site management organization (SMO) comprised of a network of physicians conducting clinical trials for pharmaceutical companies.

Vuk Zdinjak

International Law Expert Explains Tax Implications And The Search For Legitimacy In Cannabis Industry

Marijuana Industry: Viridian's President Explains Why He's Concerned About The Vape Sector

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-2.81K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

Free Cash Flow (TTM)

-2.81K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.81K

Valuation Metrics

Enterprise Value

$410.21K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

4.42

PB Ratio (TTM)

Earnings Yield % (TTM)

-61.00%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.00

Company Debt

Total Debt

$54.16K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$333.00

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.00

Volume / Avg.

108.51M / 2.70M

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.00

Market Cap

$304.29K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Neutra Corp is a research and development company that intends to market and participate in the nutraceutical space by bringing products derived from all-natural and organic origins. Along with participating in the actual nutraceutical products, the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neutra (NTRR) stock?

You can purchase shares of Neutra (OTCID:NTRR) through any online brokerage.

View our list of the best stock brokerages

Who are Neutra (NTRR) competitors?

There are no as such competitors for Neutra.

What is the forecast, or price target, for Neutra (NTRR) stock?

There is no analysis for Neutra to provide a consensus price target.

What is the current price for Neutra (NTRR)?

The stock price for Neutra (OTCID: NTRR) is $0.0001 last updated March 27, 2026 at 2:12 PM EDT.

Does Neutra (NTRR) pay a dividend?

There are no upcoming dividends for Neutra.

When is Neutra (OTCID:NTRR) reporting earnings?

Neutra does not have any upcoming earnings scheduled.

Is Neutra (NTRR) going to split?

There is no upcoming split for Neutra.

What sector and industry does Neutra (NTRR) operate in?

Neutra is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCID.

Key Statistics

Open

$0.00

Volume / Avg.

108.51M / 2.70M

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.00

Market Cap

$304.29K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Neutra Corp News

Neutra To Acquire Private Clinical Research Site Management Organization

Vuk Zdinjak

International Law Expert Explains Tax Implications And The Search For Legitimacy In Cannabis Industry

Marijuana Industry: Viridian's President Explains Why He's Concerned About The Vape Sector